Postpartum thyroiditis secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 4: Line 4:


==Overview==
==Overview==
Effective measures for the secondary prevention of [[postpartum thyroiditis]] are same as primary prevention measures. Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of [[postpartum thyroiditis]] cases.
Effective measures for the secondary prevention of [[postpartum thyroiditis]] are same as [[Postpartum thyroiditis primary prevention|primary preventive measures]]. Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of [[postpartum thyroiditis]] cases.


==Secondary Prevention==
==Secondary Prevention==
*Effective measures for the secondary prevention of [[postpartum thyroiditis]] are same as its [[Postpartum thyroiditis primary prevention|primary prevention]] measures. <ref name="pmid17284630">{{cite journal| author=Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H| title=The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. | journal=J Clin Endocrinol Metab | year= 2007 | volume= 92 | issue= 4 | pages= 1263-8 | pmid=17284630 | doi=10.1210/jc.2006-1821 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17284630  }}</ref>
*Effective measures for the secondary prevention of [[postpartum thyroiditis]] are same as its [[Postpartum thyroiditis primary prevention|primary preventive measures]]. <ref name="pmid17284630">{{cite journal| author=Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H| title=The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. | journal=J Clin Endocrinol Metab | year= 2007 | volume= 92 | issue= 4 | pages= 1263-8 | pmid=17284630 | doi=10.1210/jc.2006-1821 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17284630  }}</ref>
*Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of [[postpartum thyroiditis]] cases.<ref name="pmid20614463">{{cite journal| author=Reid SM, Middleton P, Cossich MC, Crowther CA| title=Interventions for clinical and subclinical hypothyroidism in pregnancy. | journal=Cochrane Database Syst Rev | year= 2010 | volume=  | issue= 7 | pages= CD007752 | pmid=20614463 | doi=10.1002/14651858.CD007752.pub2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20614463  }}</ref>
*Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of [[postpartum thyroiditis]] cases.<ref name="pmid20614463">{{cite journal| author=Reid SM, Middleton P, Cossich MC, Crowther CA| title=Interventions for clinical and subclinical hypothyroidism in pregnancy. | journal=Cochrane Database Syst Rev | year= 2010 | volume=  | issue= 7 | pages= CD007752 | pmid=20614463 | doi=10.1002/14651858.CD007752.pub2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20614463  }}</ref>



Latest revision as of 17:45, 15 November 2017

Postpartum thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Postpartum Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Postpartum thyroiditis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Postpartum thyroiditis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Postpartum thyroiditis secondary prevention

CDC on Postpartum thyroiditis secondary prevention

Postpartum thyroiditis secondary prevention in the news

Blogs on Postpartum thyroiditis secondary prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Postpartum thyroiditis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]

Overview

Effective measures for the secondary prevention of postpartum thyroiditis are same as primary preventive measures. Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of postpartum thyroiditis cases.

Secondary Prevention

References

  1. Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H (2007). "The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies". J Clin Endocrinol Metab. 92 (4): 1263–8. doi:10.1210/jc.2006-1821. PMID 17284630.
  2. Reid SM, Middleton P, Cossich MC, Crowther CA (2010). "Interventions for clinical and subclinical hypothyroidism in pregnancy". Cochrane Database Syst Rev (7): CD007752. doi:10.1002/14651858.CD007752.pub2. PMID 20614463.

Template:WH Template:WS